Ophthalmology and Telehealth, A Suitable Match | AAO 2023
Albert S. Khouri, M.D., says ophthalmic care lends itself to telehealth because it is image based. As with many other areas of medicine, the COVID-19 pandemic accelerated adoption.
Telehealth swept through healthcare during the early peak days of the COVID-19 epidemic, and ophthalomology was not exception.
But Albert S. Khouri, a professor of ophthalmology at the Rutgers New Jersey Medical School, says that ophthalmic care is particularly well suited to delivery via telehealth.
“A lot of the technologies that we use are image-based and are very objective, meaning there’s data generated during the encounter that lend the technology well to telemedicine,” Khouri said in an interview with Managed Healthcare Executive.
Khouri was one of the seven instructors for an educational session on innovations in teleophthalmology on Saturday at the annual meeting of the American Academy of Ophthalmology meeting in San Francisco. The other instructors were April Y Maa, M.D., Andrew G. Lee, M.D., Roomasa Channa, M.D., David J. Ramsey, M.D., and Lama A. Al-Aswad, M.D., M.P.H. The senior instructor was Gary L. Legault, M.D.
High-Dose Eylea Shows Unique Properties in nAMD and DME | AAO 2024
October 22nd 2024A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks to as long as 20 weeks for neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME).
Read More
The Link between GLP-1 Drugs and Diabetic Retinopathy Is Not So Clear | AAO 2024
Published: October 21st 2024 | Updated: October 21st 2024Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy complications in patients. But this could be an early worsening of disease unrelated to treatment.
Read More
